Overview

H.I.G. BioVentures invests in a broad range of life science companies across multiple sectors and stages of development. Our seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. We invest in companies developing novel products for significant unmet medical needs.

The H.I.G. BioVentures II fund successfully closed in March 2012 and was over-subscribed with total aggregate commitments of $268 million. more >